We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

UCB and Domainex Collaboration Provides Valuable Information on Cancer Drug Target

News   Mar 15, 2012

 
UCB and Domainex Collaboration Provides Valuable Information on Cancer Drug Target
 
 
 

RELATED ARTICLES

Antibody Therapy That Trains Phagocytes to Destroy Tumors Is Tested in Patients

News

An immunotherapeutic antibody therapy re-educates macrophages to activate passivated cytotoxic T cells to kill cancer. The antibody therapy prevented the growth of tumors in several mouse models. The development of the therapy has now progressed to patient testing in a phase I/II clinical trial.

READ MORE

Minimizing Toxicity of Breast Cancer Treatment

News

De-escalation of treatment strategies aims to minimize toxicity while maintaining efficacy.

READ MORE

New Method to Detect Cancer Cells Faster

News

The days - or even weeks - spent waiting for the results of a cancer-screening test can feel like an eternity. Especially when early diagnosis and quick action are tied to better outcomes. Now, a new technique to analyze proteins expressed on cancer cells shows promise in more rapidly detecting these cell types.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE